Blog

Dec 11, 2024, 10:33

Pemetrexed plus platinum ± pembrolizumab in untreated metastatic nonsquamous NSCLC

ESMO shared on X:

“For Annals of Oncology Anniversary we highlight this 2023 top-cited paper:’

Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189 – Annals of Oncology

Authors: D. Rodríguez-Abreu, S.F. Powell, M.J. Hochmair, S. Gadgeel, E. Esteban, E. Felip, G. Speranza, F. De Angelis, M. Dómine, S.Y. Cheng, H.G. Bischoff, N. Peled, M. Reck, R. Hui, E.B. Garon, M. Boyer, T. Kurata, J. Yang, M.C. Pietanza, F. Souza, M.C. Garassino

cancer D. Rodriguez-Abreu E. Esteban E. Felip E.B. Garon ESMO F. De Angelis F. Souza G. Speranza H.G. Bischoff J. Yang M C Garassino M. Boyer M. Dómine M. Reck M.C. Pietanza M.J. Hochmair N. Peled NSCLC OncoDaily Oncology R. Hui S. Gadgeel S.F. Powell S.Y. Cheng T. Kurata

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

"The Doctor Who Always Has Candies in His Pocket": A Conversation with Professor Guangchao Zhang, Pioneer of Pediatric Surgical Oncology in China

Highlights from Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer - Day 3

Wanda Sykes and Breast Cancer: How She Went Against, How She Survived, and More

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Special Coverage